These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7498246

  • 1. Cellular processing of apolipoprotein B-containing lipoproteins from young post-infarction patients and healthy controls.
    Tornvall P, Regnström J, Hamsten A.
    Eur J Clin Invest; 1995 Sep; 25(9):699-707. PubMed ID: 7498246
    [Abstract] [Full Text] [Related]

  • 2. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH, Gotto AM, Jackson RL, Patsch JR, Sybers HD, Taunton OD, Yeshurun DL, Smith LC.
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [Abstract] [Full Text] [Related]

  • 3. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [Abstract] [Full Text] [Related]

  • 4. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.
    Am J Cardiol; 1995 Jul 13; 76(2):129A-135A. PubMed ID: 7604788
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 13; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 8. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.
    Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B.
    J Clin Invest; 1981 Feb 13; 67(2):493-502. PubMed ID: 6257763
    [Abstract] [Full Text] [Related]

  • 9. Role of lipoproteins and 3-hydroxy-3-methylglutaryl coenzyme A reductase in progesterone production by cultured bovine granulosa cells.
    Savion N, Laherty R, Cohen D, Lui GM, Gospodarowicz D.
    Endocrinology; 1982 Jan 13; 110(1):13-22. PubMed ID: 6274615
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Remnant-like very-low-density lipoprotein isolated from hypertriglyceridemic patients by immunoaffinity chromatography suppressed 3-hydroxy-3-methylglutaryl coenzyme A activity of cultured human skin fibroblasts.
    Shige H, Ishikawa T, Ikewaki K, Nishiwaki M, Higashi K, Nakajima K, Nakamura H.
    Clin Chim Acta; 1997 Feb 17; 258(2):145-58. PubMed ID: 9074812
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
    Chan DC, Watts GF, Barrett PH, Mori TA, Beilin LJ, Redgrave TG.
    J Clin Endocrinol Metab; 2002 May 17; 87(5):2283-9. PubMed ID: 11994377
    [Abstract] [Full Text] [Related]

  • 13. Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.
    Kasim SE, Elovson J, Khilnani S, Almario RU, Jen KL.
    Atherosclerosis; 1993 Dec 17; 104(1-2):147-52. PubMed ID: 8141838
    [Abstract] [Full Text] [Related]

  • 14. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone.
    Beg ZH, Reznikov DC, Avigan J.
    Arch Biochem Biophys; 1986 Jan 17; 244(1):310-22. PubMed ID: 3004340
    [Abstract] [Full Text] [Related]

  • 15. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES, Tikkanen MJ, Cole TG, Davie JM, Schonfeld G.
    J Clin Invest; 1985 Feb 17; 75(2):361-9. PubMed ID: 3973009
    [Abstract] [Full Text] [Related]

  • 16. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV.
    Metabolism; 2000 Feb 17; 49(2):167-77. PubMed ID: 10690940
    [Abstract] [Full Text] [Related]

  • 17. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2006 Jun 17; 26(6):1350-6. PubMed ID: 16574893
    [Abstract] [Full Text] [Related]

  • 18. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P, Heinonen T, Shurzinske L, Black DM.
    Atherosclerosis; 1997 Aug 17; 133(1):123-33. PubMed ID: 9258416
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipoprotein E.
    Yamada N, Shames DM, Stoudemire JB, Havel RJ.
    Proc Natl Acad Sci U S A; 1986 May 17; 83(10):3479-83. PubMed ID: 3458191
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov 17; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.